In biotech, translating bold ideas into real-world therapies is a long game. Scientific breakthroughs often take years — sometimes decades — to reach the clinic. For Singapore-headquartered Hummingbird Bioscience, that journey is no exception. But it’s also a story that reveals how the right ecosystem, patient capital, and strategic partnerships can turn that long road into meaningful progress.